Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study

Background. Imiquimod 5% is licensed for the treatment of external genital warts, superficial basal cell carcinoma, and actinic keratosis (AK) and is being used experimentally in various other dermato-oncological conditions. Objective. This observational study shall show that nonmelanoma skin cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopera, Daisy, Kerl, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037597/
https://www.ncbi.nlm.nih.gov/pubmed/24900953
http://dx.doi.org/10.1155/2014/135916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037597/
https://www.ncbi.nlm.nih.gov/pubmed/24900953
http://dx.doi.org/10.1155/2014/135916

Ejemplares similares